Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Hellings, Peter W" or (type any "bookEditor journalEditor issueEditor" and editor="Hellin...

Add to list
- Journal Article
Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds

Chien-Chia Chuang, Isabelle Guillemin, Claus Bachert, Stella E Lee, Peter W Hellings, Wytske J Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh and Asif H. Khan (UGent)

(2022) The Laryngoscope. 132(2). p.259-264
Add to list
- Conference Paper
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter W Hellings, Anju T Peters, Adam M Chaker, Enrico Heffler, Haixin Zhang, Amy Praestgaard, Scott Nash, Asif H. Khan (UGent) , Shahid Siddiqui and Juby A Jacob-Nara

(2021) International forum of allergy & rhinology.
Add to list
- Journal Article
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

Martin Desrosiers, Leda P Mannent, Nikhil Amin, G Walter Canonica, Peter W Hellings, Philippe Gevaert, Joaquim Mullol, Stella E Lee, Shigeharu Fujieda and Asif H. Khan (UGent)

(2021) Rhinology. 59(3). p.301-311
Add to list
- Journal Article
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert and Asif H. Khan (UGent)

(2021) The Journal of Allergy and Clinical Immunology: In Practice.
Add to list
- Journal Article
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Claus Bachert (UGent) , Peter W Hellings, Joaquim Mullol, Robert M Naclerio, Jingdong Chao, Nikhil Amin, Annette Grabher, Brian N Swanson, Jennifer D Hamilton and Asif H. Khan (UGent)

(2019) The Journal of Allergy and Clinical Immunology: In Practice. 7(7). p.2447-2449
Add to list
- Journal Article
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert (UGent) , Joseph K Han, Martin Desrosiers, Peter W Hellings, Nikhil Amin, Stella E Lee, Joaquim Mullol, Leon S Greos, John V Bosso and Tanya M Laidlaw

(2019) The Lancet. 394(10209). p.1638-1650
Add to list
- Journal Article
- A1
- open access
EUFOREA consensus on biologics for CRSwNP with or without asthma

Wytske J Fokkens, Valerie Lund, Claus Bachert (UGent) , Joaquim Mullol, Leif Bjermer, Jean Bousquet, Giorgio W Canonica, Lauren Deneyer, Martin Desrosiers, Zuzana Diamant, et al.

(2019) ALLERGY. 74(12). p.2312-2319
Add to list
The GALEN rhinosinusitis cohort : chronic rhinosinusitis with nasal polyps affects health-related quality of life

Asif Khan, Thi Minh Thao Huynh, GRIET VANDEPLAS (UGent) , Vijay N Joish, Leda P Mannent, Peter Tomassen (UGent) , Thibaut Van Zele (UGent) , Lars-Olaf Cardell (UGent) , Julia Arebro, Heidi Olze, et al.

(2019) RHINOLOGY. 57(5). p.343-351
Add to list
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert (UGent) , Joseph K Han, Martin Desrosiers, Peter W Hellings, Nikhil Amin, Stella E Lee, Joaquim Mullol, Leon S Greos, John V Bosso, Tanya M Laidlaw, et al.

(2019) LANCET. 394(10209). p.1638-1650
Add to list
Adherence to treatment in allergic rhinitis using mobile technology : the MASK study

Enrica Menditto, Elisio Costa, Luis Midão, Sinthia Bosnic‐Anticevich, Ettore Novellino, Slawomir Bialek, Vitalis Briedis, Alpana Mair, Rojin Rajabian‐Soderlund, Sylvie Arnavielhe, et al.

(2019) CLINICAL AND EXPERIMENTAL ALLERGY. 49(4). p.442-460

Academic Bibliography

Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

EUFOREA consensus on biologics for CRSwNP with or without asthma

The GALEN rhinosinusitis cohort : chronic rhinosinusitis with nasal polyps affects health-related quality of life

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Adherence to treatment in allergic rhinitis using mobile technology : the MASK study

Contents

Support

Contact